Covid Vaccine Application

COVID, Shingles

FDA halts publication of COVID, shingles vaccine studies

News of the studies being pulled comes weeks after the CDC decided it wouldn't publish a report showing last winter's covid vaccine cut the likelihood of hospitalizations.

· 11h

FDA stopped studies supporting COVID-19 and shingles vaccine safety

· 1d

US FDA Blocked Research Publication That COVID and Shingles Vaccines Are Safe, NYT Reports

· 11h

FDA blocks studies finding COVID, shingles vaccines safe

Although large studies of the COVID-19 and shingles vaccines found few risks and overall safety, the U.S. Food and Drug Administration has blocked their publication, even as millions of dollars in tax...

· 20h

FDA withdraws publication of COVID, shingles vaccine research findings

· 1d

F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe

Medscape

First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval

Combriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains and SARS-CoV-2 targets.

Pfizer asks FDA to approve its experimental antiviral pill for COVID-19

The decisions by Pfizer and Merck to share their COVID-19 drug patents stands in stark contrast to the refusal of Pfizer and other vaccine-makers to release their vaccine recipes

abc7NY

Pfizer and BioNTech begin application for full FDA approval of their COVID-19 vaccine

Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the first Covid-19 vaccine in the United States to be ...

15don MSN

Moderna wins EU approval for combined flu, COVID shot for older adults

April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention of influenza and COVID-19 in adults 50 years of age and older. Here are the details: • The approval follows a positive recommendation from the European Medicines Agency,